• AMG 487: Precision CXCR3 Antagonist for Macrophage Assays

  2026-06-11

  AMG 487 empowers researchers to dissect CXCR3-mediated signaling and macrophage polarization with unmatched selectivity and reproducibility. Its robust inhibition profile and proven impact on acute lung injury models set it apart for inflammation and cancer biology workflows.

• CTCF Drives Pancreatic Cancer via FLG-AS1–Mediated Macrophag

  2026-06-11

  This study uncovers how CTCF promotes pancreatic ductal adenocarcinoma progression through FLG-AS1–dependent recruitment of epigenetic regulators, leading to histone lactylation and M2 macrophage polarization. The findings provide mechanistic insight into tumor–immune interactions and highlight CTCF as a potential immunotherapeutic target.

• Necroptosis in Lung Epithelium After Ricin Exposure: Mechani

  2026-06-10

  Kempen et al. (2023) identify a novel necroptotic pathway in lung epithelial cells triggered by ricin toxin and bystander inflammation, mediated by the release of FasL and HMGB1 from apoptotic monocytes. This study advances understanding of pulmonary injury mechanisms in toxin-mediated diseases and highlights the complexity of cell death signaling in acute respiratory distress.

• Trametinib (GSK1120212): Precision MEK Inhibition in Transla

  2026-06-10

  Explore how Trametinib (GSK1120212), a potent ATP-noncompetitive MEK1/2 inhibitor, is revolutionizing translational oncology research. This thought-leadership article synthesizes mechanistic insight, protocol guidance, and strategic perspective—including the latest discoveries linking MEK-ERK pathway modulation to telomerase regulation and cell cycle control. Researchers will find actionable advice for experimental design and a forward-looking view on targeting tumor heterogeneity and adaptive resistance. Differentiated by its integration of new findings on DNA repair and telomerase expression, this piece goes beyond standard product literature to offer a roadmap for next-generation cancer research.

• Aurora A Kinase Shapes Trained Immunity via SAM Metabolism

  2026-06-09

  Li et al. uncover a novel role for Aurora kinase A in sustaining trained immunity by regulating endogenous S-adenosylmethionine (SAM) metabolism in innate immune cells. Their findings clarify how Aurora A kinase influences histone methylation and inflammatory gene expression, highlighting mechanistic links between metabolic and epigenetic pathways in immunity.

• Urolithin A: Benchmarking Mitochondrial Quality in Cellular

  2026-06-09

  Discover how Urolithin A (3,8-dihydroxy-6H-benzo[c]chromen-6-one) uniquely advances mitochondrial biogenesis research and cellular quality control. This article provides a protocol-driven, comparative framework for leveraging Urolithin A in advanced studies, offering new insights not found in existing literature.

• Osthole Regulates m6A-TGM2 Axis to Suppress RA and RA-ILD Pr

  2026-06-08

  This study uncovers how the natural compound osthole inhibits rheumatoid arthritis (RA) and its interstitial lung disease (ILD) complication by targeting N6-methyladenosine (m6A)-modified TGM2. The work delineates a positive feedback circuit involving TGM2, Myc, and WTAP, providing mechanistic insights and identifying TGM2 as a promising therapeutic target in RA-ILD.

• Antibody Targeting of SCUBE3 Disrupts Oncogenic and Immune P

  2026-06-08

  This study identifies secretory protein SCUBE3 as a key mediator of cancer progression, therapy resistance, and immune evasion. Antibody-mediated targeting of SCUBE3 interrupts oncogenic signaling and restores antitumor immunity, providing a novel therapeutic avenue across cancer types.

• Canagliflozin: SGLT2 Inhibitor Workflows for Renal Research

  2026-06-07

  Canagliflozin empowers researchers to dissect renal glucose reabsorption and mitochondrial remodeling in diabetic and hypertensive models. This guide translates the latest study-backed protocols and troubleshooting insights into actionable strategies for metabolic and kidney research.

• Bone Transport Heals Diabetic Foot Ulcers via TGF-β1 Pathway

  2026-06-06

  This study demonstrates that bone transport surgery significantly accelerates diabetic foot ulcer healing by activating the TGF-β1/TGFBR1 signaling axis, which promotes both angiogenesis and osteo-immune modulation. The findings offer mechanistic insights and highlight the TGF-β1 pathway as a promising therapeutic target for chronic wound repair.

• Mitochondrial Calcium Signaling Suppresses Ferroptosis in Tu

  2026-06-05

  This study reveals that mitochondrial calcium influx via the MCU directly represses ferroptosis in cancer cells by promoting acetylation of GPX4, a key lipid peroxidation defense enzyme. These findings connect mitochondrial metabolism, calcium signaling, and regulated cell death, providing mechanistic insights for tumor cell metabolism and apoptosis research.

• AMG 487: Unveiling the CXCR3 Axis in Macrophage Modulation

  2026-06-05

  This thought-leadership article explores how AMG 487, a potent CXCR3 antagonist from APExBIO, is redefining the mechanistic and translational landscape of macrophage polarization and inflammation research. By dissecting recent mechanistic advances and highlighting protocol best practices, we offer strategic guidance for translational researchers seeking to harness CXCR3 inhibition in disease modeling and therapeutic innovation.

• 2-Hydroxypropyl-β-cyclodextrin for Solubility Enhancement Wo

  2026-06-04

  2-Hydroxypropyl-β-cyclodextrin addresses the persistent challenge of solubilizing hydrophobic, poorly water-soluble compounds in pharmaceutical and biochemical research, especially those with aromatic or phenyl groups. Its validated role is as a drug formulation excipient or for solubility improvement; use outside these parameters is not supported by current documentation.

• ERAD-Hijacking ERADECs: Targeting Transmembrane Protein Degr

  2026-06-04

  Song et al. present ERAD-engaging chimeras (ERADECs), a novel small-molecule platform that harnesses the ER-associated degradation pathway for highly efficient and selective degradation of transmembrane proteins. This approach overcomes longstanding barriers in targeted protein degradation and has broad implications for both therapeutic development and mechanistic research.

• Cytoskeleton-Dependent Autophagy Triggered by Mechanical Str

  2026-06-03

  The reference study establishes that mechanical stress induces autophagy in human cells via a cytoskeleton-dependent mechanism, with microfilaments serving as primary mediators and microtubules playing a supportive role. These findings clarify mechanotransduction pathways linking physical forces to autophagic responses, deepening our understanding of cell homeostasis under biomechanical stimuli.

452 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page